Supporting our observations, current tau-imaging studies show that the subcortical areas are the primary affected regions in different clinical subtypes [40]; however, current tau-imaging may show off target binding and they have not been performed in end-stage PSP cases. This evidence concerns the gene MAPT and supranuclear palsy, progressive, 1.